The Summit takes place in London on 20-22 June 2023, and comprises 4 conference programs from strategies on Modulating the Tumour Microenvironment to various treatment modalities including Next-Generation Cell-Based Immunotherapies; Bispecific and Multi-Specific Antibody Therapeutics, and Gamma Delta Immunotherapy.
Highlights include a Plenary Keynote Session featuring 4 distinguished Keynote Speakers; engaging Breakout Discussions that bring peers together to chat about current trends and latest developments on the most pressing or contentious topics; a balanced faculty of industry and academia speakers; and an Exhibit Hall showcasing the technology leaders in the IO space.